Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248)

Yoav Golan; Herbert L. Dupont; Fernando Aldomiro; Erin H. Jensen; Mary E. Hanson; Mary Beth Dorr

doi:10.1093/ofid/ofaa629

Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248)

Yoav Golan, Herbert L. Dupont, Fernando Aldomiro, Erin H. Jensen, Mary E. Hanson, Mary Beth Dorr

Research output: Contribution to journal › Comment/debate

Abstract

In "Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials", Open Forum Infectious Diseases, Volume 7, Issue 7, July 2020, ofaa248, few errors occurred in Figure 1 and has been corrected. (Figure Presented).

Original language	English
Article number	ofaa629
Journal	Open Forum Infectious Diseases
Volume	8
Issue number	1
DOIs	https://doi.org/10.1093/ofid/ofaa629
State	Published - 1 Jan 2021
Externally published	Yes

ASJC Scopus subject areas

Oncology
Clinical Neurology

Access to Document

10.1093/ofid/ofaa629

Fingerprint

Dive into the research topics of 'Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248)'. Together they form a unique fingerprint.

Cite this

Golan, Y., Dupont, H. L., Aldomiro, F., Jensen, E. H., Hanson, M. E., & Dorr, M. B. (2021). Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248). Open Forum Infectious Diseases, 8(1), Article ofaa629. https://doi.org/10.1093/ofid/ofaa629

@article{03e040cc7e6d4a428a2cdad3eb4298d1,

title = "Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248)",

abstract = "In {"}Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials{"}, Open Forum Infectious Diseases, Volume 7, Issue 7, July 2020, ofaa248, few errors occurred in Figure 1 and has been corrected. (Figure Presented).",

author = "Yoav Golan and Dupont, {Herbert L.} and Fernando Aldomiro and Jensen, {Erin H.} and Hanson, {Mary E.} and Dorr, {Mary Beth}",

year = "2021",

month = jan,

day = "1",

doi = "10.1093/ofid/ofaa629",

language = "English",

volume = "8",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "1",

}

Golan, Y, Dupont, HL, Aldomiro, F, Jensen, EH, Hanson, ME & Dorr, MB 2021, 'Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248)', Open Forum Infectious Diseases, vol. 8, no. 1, ofaa629. https://doi.org/10.1093/ofid/ofaa629

Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248). / Golan, Yoav; Dupont, Herbert L.; Aldomiro, Fernando et al.
In: Open Forum Infectious Diseases, Vol. 8, No. 1, ofaa629, 01.01.2021.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248)

AU - Golan, Yoav

AU - Dupont, Herbert L.

AU - Aldomiro, Fernando

AU - Jensen, Erin H.

AU - Hanson, Mary E.

AU - Dorr, Mary Beth

PY - 2021/1/1

Y1 - 2021/1/1

N2 - In "Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials", Open Forum Infectious Diseases, Volume 7, Issue 7, July 2020, ofaa248, few errors occurred in Figure 1 and has been corrected. (Figure Presented).

AB - In "Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials", Open Forum Infectious Diseases, Volume 7, Issue 7, July 2020, ofaa248, few errors occurred in Figure 1 and has been corrected. (Figure Presented).

UR - http://www.scopus.com/inward/record.url?scp=85100834774&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofaa629

DO - 10.1093/ofid/ofaa629

M3 - Comment/debate

C2 - 33511241

AN - SCOPUS:85100834774

SN - 2328-8957

VL - 8

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

IS - 1

M1 - ofaa629

ER -

Golan Y, Dupont HL, Aldomiro F, Jensen EH, Hanson ME, Dorr MB. Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248). Open Forum Infectious Diseases. 2021 Jan 1;8(1):ofaa629. doi: 10.1093/ofid/ofaa629

Erratum: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from 2 Randomized Clinical Trials (Open Forum Infectious Diseases (2020) 7:7 (ofaa248) DOI: 10.1093/ofid/ofaa248)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this